SCHEMBL23601464

SCHEMBL23601464

CN(c1cc(F)cc(CCC2(C(F)(F)F)CC2)c1)c1nc2nncn2c2ccc(F)c(F)c12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23601837 0.91
SCHEMBL23601526 0.90 SMN1; SMN2 (0.30)
SCHEMBL23601477 0.87
SCHEMBL23601381 0.85
SCHEMBL23601300 0.81 SMN1; SMN2 (0.32)
SCHEMBL23601714 0.80
SCHEMBL23601764 0.79 MAPT (0.30)
SCHEMBL23576840 0.79
SCHEMBL31169407 0.79
SCHEMBL23601581 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021130638-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS CARNA BIOSCIENCES, INC. (JP) 2021-07-01 WO disclosed